Medicamen Biotech Ltd Q2 FY2024-2025 Results: Summary
Revenue | ₹45.03Cr |
Net Profits | ₹1.46Cr |
Net Profit Margins | 3.24% |
Highlights
Revenue:
Medicamen Biotech Ltd’s revenue jumped 2.13% since last year same period to ₹45.03Cr in the Q2 2024-2025. On a quarterly growth basis, Medicamen Biotech Ltd has generated 3.21% jump in its revenue since last 3-months.
Net Profits:
Medicamen Biotech Ltd’s net profit fell -3.31% since last year same period to ₹1.46Cr in the Q2 2024-2025. On a quarterly growth basis, Medicamen Biotech Ltd has generated 8.15% jump in its net profits since last 3-months.
Net Profit Margins:
Medicamen Biotech Ltd’s net profit margin fell -5.33% since last year same period to 3.24% in the Q2 2024-2025. On a quarterly growth basis, Medicamen Biotech Ltd has generated 4.79% jump in its net profit margins since last 3-months.
